Repurposing Fragile X Drugs to Inhibit SARS-CoV-2 Viral Reproduction is a research paper published in Frontiers in Cell and Developmental Biology (2020). On theSindex it has a DataRank of 0.466. It has been cited 6 times, with 5 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0.174
From 4 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 5 citers.
U.S. Department of Agriculture
Grant: 2018-67001-28266
National Institutes of Health
Grant: HD097067
National Institutes of Health
Grant: HHSN272201400008C
Japan Agency for Medical Research and Development
Grant: 19fk0108113
NICHD NIH HHS
Grant: R03 HD097067
National Institutes of Health
Grant: 5R03HD097067-02
Does Soy Infant Formula Exacerbate Seizures in Fragile X?
FWCI
0.32
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals